Global Antiandrogen Market Growth (Status and Outlook) 2024-2030

May 2024 | 110 pages | ID: G02B265A8844EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Antiandrogen market size is projected to grow from US$ 6622.8 million in 2023 to US$ 9833.4 million in 2030; it is expected to grow at a CAGR of 5.8% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Antiandrogen Industry Forecast” looks at past sales and reviews total world Antiandrogen sales in 2023, providing a comprehensive analysis by region and market sector of projected Antiandrogen sales for 2024 through 2030. With Antiandrogen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiandrogen industry.

This Insight Report provides a comprehensive analysis of the global Antiandrogen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antiandrogen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiandrogen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiandrogen and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiandrogen.

United States market for Antiandrogen is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Antiandrogen is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Antiandrogen is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Antiandrogen players cover Pfizer, Johnson & Johnson, AstraZeneca, Astellas and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiandrogen market by product type, application, key players and key regions and countries.

Segmentation by type

• Steroidal Antiandrogen
• Nonsteroidal Antiandrogen

Segmentation by application

• Prostate Cancer
• Benign Prostatic Hyperplasia
• Polycystic Ovary Syndrome (POCS)
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Merck
• Sanofi
• Orion Corporation
• Hengrui
• Bayer
• Schering-Plough
• Hinova Pharma
• Jiangsu Hengrui Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antiandrogen Market Size 2019-2030
  2.1.2 Antiandrogen Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Antiandrogen Segment by Type
  2.2.1 Steroidal Antiandrogen
  2.2.2 Nonsteroidal Antiandrogen
2.3 Antiandrogen Market Size by Type
  2.3.1 Antiandrogen Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Antiandrogen Market Size Market Share by Type (2019-2024)
2.4 Antiandrogen Segment by Application
  2.4.1 Prostate Cancer
  2.4.2 Benign Prostatic Hyperplasia
  2.4.3 Polycystic Ovary Syndrome (POCS)
  2.4.4 Others
2.5 Antiandrogen Market Size by Application
  2.5.1 Antiandrogen Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Antiandrogen Market Size Market Share by Application (2019-2024)

3 ANTIANDROGEN MARKET SIZE BY PLAYER

3.1 Antiandrogen Market Size Market Share by Players
  3.1.1 Global Antiandrogen Revenue by Players (2019-2024)
  3.1.2 Global Antiandrogen Revenue Market Share by Players (2019-2024)
3.2 Global Antiandrogen Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTIANDROGEN BY REGIONS

4.1 Antiandrogen Market Size by Regions (2019-2024)
4.2 Americas Antiandrogen Market Size Growth (2019-2024)
4.3 APAC Antiandrogen Market Size Growth (2019-2024)
4.4 Europe Antiandrogen Market Size Growth (2019-2024)
4.5 Middle East & Africa Antiandrogen Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Antiandrogen Market Size by Country (2019-2024)
5.2 Americas Antiandrogen Market Size by Type (2019-2024)
5.3 Americas Antiandrogen Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antiandrogen Market Size by Region (2019-2024)
6.2 APAC Antiandrogen Market Size by Type (2019-2024)
6.3 APAC Antiandrogen Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antiandrogen by Country (2019-2024)
7.2 Europe Antiandrogen Market Size by Type (2019-2024)
7.3 Europe Antiandrogen Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antiandrogen by Region (2019-2024)
8.2 Middle East & Africa Antiandrogen Market Size by Type (2019-2024)
8.3 Middle East & Africa Antiandrogen Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTIANDROGEN MARKET FORECAST

10.1 Global Antiandrogen Forecast by Regions (2025-2030)
  10.1.1 Global Antiandrogen Forecast by Regions (2025-2030)
  10.1.2 Americas Antiandrogen Forecast
  10.1.3 APAC Antiandrogen Forecast
  10.1.4 Europe Antiandrogen Forecast
  10.1.5 Middle East & Africa Antiandrogen Forecast
10.2 Americas Antiandrogen Forecast by Country (2025-2030)
  10.2.1 United States Antiandrogen Market Forecast
  10.2.2 Canada Antiandrogen Market Forecast
  10.2.3 Mexico Antiandrogen Market Forecast
  10.2.4 Brazil Antiandrogen Market Forecast
10.3 APAC Antiandrogen Forecast by Region (2025-2030)
  10.3.1 China Antiandrogen Market Forecast
  10.3.2 Japan Antiandrogen Market Forecast
  10.3.3 Korea Antiandrogen Market Forecast
  10.3.4 Southeast Asia Antiandrogen Market Forecast
  10.3.5 India Antiandrogen Market Forecast
  10.3.6 Australia Antiandrogen Market Forecast
10.4 Europe Antiandrogen Forecast by Country (2025-2030)
  10.4.1 Germany Antiandrogen Market Forecast
  10.4.2 France Antiandrogen Market Forecast
  10.4.3 UK Antiandrogen Market Forecast
  10.4.4 Italy Antiandrogen Market Forecast
  10.4.5 Russia Antiandrogen Market Forecast
10.5 Middle East & Africa Antiandrogen Forecast by Region (2025-2030)
  10.5.1 Egypt Antiandrogen Market Forecast
  10.5.2 South Africa Antiandrogen Market Forecast
  10.5.3 Israel Antiandrogen Market Forecast
  10.5.4 Turkey Antiandrogen Market Forecast
  10.5.5 GCC Countries Antiandrogen Market Forecast
10.6 Global Antiandrogen Forecast by Type (2025-2030)
10.7 Global Antiandrogen Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Antiandrogen Product Offered
  11.1.3 Pfizer Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Information
  11.2.2 Johnson & Johnson Antiandrogen Product Offered
  11.2.3 Johnson & Johnson Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson Latest Developments
11.3 AstraZeneca
  11.3.1 AstraZeneca Company Information
  11.3.2 AstraZeneca Antiandrogen Product Offered
  11.3.3 AstraZeneca Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 AstraZeneca Main Business Overview
  11.3.5 AstraZeneca Latest Developments
11.4 Astellas
  11.4.1 Astellas Company Information
  11.4.2 Astellas Antiandrogen Product Offered
  11.4.3 Astellas Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Astellas Main Business Overview
  11.4.5 Astellas Latest Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Antiandrogen Product Offered
  11.5.3 Merck Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Merck Main Business Overview
  11.5.5 Merck Latest Developments
11.6 Sanofi
  11.6.1 Sanofi Company Information
  11.6.2 Sanofi Antiandrogen Product Offered
  11.6.3 Sanofi Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Sanofi Main Business Overview
  11.6.5 Sanofi Latest Developments
11.7 Orion Corporation
  11.7.1 Orion Corporation Company Information
  11.7.2 Orion Corporation Antiandrogen Product Offered
  11.7.3 Orion Corporation Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Orion Corporation Main Business Overview
  11.7.5 Orion Corporation Latest Developments
11.8 Hengrui
  11.8.1 Hengrui Company Information
  11.8.2 Hengrui Antiandrogen Product Offered
  11.8.3 Hengrui Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Hengrui Main Business Overview
  11.8.5 Hengrui Latest Developments
11.9 Bayer
  11.9.1 Bayer Company Information
  11.9.2 Bayer Antiandrogen Product Offered
  11.9.3 Bayer Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Bayer Main Business Overview
  11.9.5 Bayer Latest Developments
11.10 Schering-Plough
  11.10.1 Schering-Plough Company Information
  11.10.2 Schering-Plough Antiandrogen Product Offered
  11.10.3 Schering-Plough Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Schering-Plough Main Business Overview
  11.10.5 Schering-Plough Latest Developments
11.11 Hinova Pharma
  11.11.1 Hinova Pharma Company Information
  11.11.2 Hinova Pharma Antiandrogen Product Offered
  11.11.3 Hinova Pharma Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Hinova Pharma Main Business Overview
  11.11.5 Hinova Pharma Latest Developments
11.12 Jiangsu Hengrui Pharmaceuticals
  11.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
  11.12.2 Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Offered
  11.12.3 Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
  11.12.5 Jiangsu Hengrui Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antiandrogen Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Steroidal Antiandrogen
Table 3. Major Players of Nonsteroidal Antiandrogen
Table 4. Antiandrogen Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Antiandrogen Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Antiandrogen Market Size Market Share by Type (2019-2024)
Table 7. Antiandrogen Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Antiandrogen Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Antiandrogen Market Size Market Share by Application (2019-2024)
Table 10. Global Antiandrogen Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Antiandrogen Revenue Market Share by Player (2019-2024)
Table 12. Antiandrogen Key Players Head office and Products Offered
Table 13. Antiandrogen Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Antiandrogen Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Antiandrogen Market Size Market Share by Regions (2019-2024)
Table 18. Global Antiandrogen Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Antiandrogen Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Antiandrogen Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Antiandrogen Market Size Market Share by Country (2019-2024)
Table 22. Americas Antiandrogen Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Antiandrogen Market Size Market Share by Type (2019-2024)
Table 24. Americas Antiandrogen Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Antiandrogen Market Size Market Share by Application (2019-2024)
Table 26. APAC Antiandrogen Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Antiandrogen Market Size Market Share by Region (2019-2024)
Table 28. APAC Antiandrogen Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Antiandrogen Market Size Market Share by Type (2019-2024)
Table 30. APAC Antiandrogen Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Antiandrogen Market Size Market Share by Application (2019-2024)
Table 32. Europe Antiandrogen Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Antiandrogen Market Size Market Share by Country (2019-2024)
Table 34. Europe Antiandrogen Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Antiandrogen Market Size Market Share by Type (2019-2024)
Table 36. Europe Antiandrogen Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Antiandrogen Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Antiandrogen Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Antiandrogen Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Antiandrogen Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Antiandrogen Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Antiandrogen Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Antiandrogen Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Antiandrogen
Table 45. Key Market Challenges & Risks of Antiandrogen
Table 46. Key Industry Trends of Antiandrogen
Table 47. Global Antiandrogen Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Antiandrogen Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Antiandrogen Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Antiandrogen Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Pfizer Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 52. Pfizer Antiandrogen Product Offered
Table 53. Pfizer Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Pfizer Main Business
Table 55. Pfizer Latest Developments
Table 56. Johnson & Johnson Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 57. Johnson & Johnson Antiandrogen Product Offered
Table 58. Johnson & Johnson Main Business
Table 59. Johnson & Johnson Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Johnson & Johnson Latest Developments
Table 61. AstraZeneca Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 62. AstraZeneca Antiandrogen Product Offered
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. AstraZeneca Latest Developments
Table 66. Astellas Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 67. Astellas Antiandrogen Product Offered
Table 68. Astellas Main Business
Table 69. Astellas Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Astellas Latest Developments
Table 71. Merck Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 72. Merck Antiandrogen Product Offered
Table 73. Merck Main Business
Table 74. Merck Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Merck Latest Developments
Table 76. Sanofi Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 77. Sanofi Antiandrogen Product Offered
Table 78. Sanofi Main Business
Table 79. Sanofi Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Sanofi Latest Developments
Table 81. Orion Corporation Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 82. Orion Corporation Antiandrogen Product Offered
Table 83. Orion Corporation Main Business
Table 84. Orion Corporation Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Orion Corporation Latest Developments
Table 86. Hengrui Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 87. Hengrui Antiandrogen Product Offered
Table 88. Hengrui Main Business
Table 89. Hengrui Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Hengrui Latest Developments
Table 91. Bayer Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 92. Bayer Antiandrogen Product Offered
Table 93. Bayer Main Business
Table 94. Bayer Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Bayer Latest Developments
Table 96. Schering-Plough Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 97. Schering-Plough Antiandrogen Product Offered
Table 98. Schering-Plough Main Business
Table 99. Schering-Plough Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 100. Schering-Plough Latest Developments
Table 101. Hinova Pharma Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 102. Hinova Pharma Antiandrogen Product Offered
Table 103. Hinova Pharma Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Hinova Pharma Main Business
Table 105. Hinova Pharma Latest Developments
Table 106. Jiangsu Hengrui Pharmaceuticals Details, Company Type, Antiandrogen Area Served and Its Competitors
Table 107. Jiangsu Hengrui Pharmaceuticals Antiandrogen Product Offered
Table 108. Jiangsu Hengrui Pharmaceuticals Main Business
Table 109. Jiangsu Hengrui Pharmaceuticals Antiandrogen Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 110. Jiangsu Hengrui Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antiandrogen Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiandrogen Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Antiandrogen Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Antiandrogen Sales Market Share by Country/Region (2023)
Figure 8. Antiandrogen Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Antiandrogen Market Size Market Share by Type in 2023
Figure 10. Antiandrogen in Prostate Cancer
Figure 11. Global Antiandrogen Market: Prostate Cancer (2019-2024) & ($ Millions)
Figure 12. Antiandrogen in Benign Prostatic Hyperplasia
Figure 13. Global Antiandrogen Market: Benign Prostatic Hyperplasia (2019-2024) & ($ Millions)
Figure 14. Antiandrogen in Polycystic Ovary Syndrome (POCS)
Figure 15. Global Antiandrogen Market: Polycystic Ovary Syndrome (POCS) (2019-2024) & ($ Millions)
Figure 16. Antiandrogen in Others
Figure 17. Global Antiandrogen Market: Others (2019-2024) & ($ Millions)
Figure 18. Global Antiandrogen Market Size Market Share by Application in 2023
Figure 19. Global Antiandrogen Revenue Market Share by Player in 2023
Figure 20. Global Antiandrogen Market Size Market Share by Regions (2019-2024)
Figure 21. Americas Antiandrogen Market Size 2019-2024 ($ Millions)
Figure 22. APAC Antiandrogen Market Size 2019-2024 ($ Millions)
Figure 23. Europe Antiandrogen Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa Antiandrogen Market Size 2019-2024 ($ Millions)
Figure 25. Americas Antiandrogen Value Market Share by Country in 2023
Figure 26. United States Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC Antiandrogen Market Size Market Share by Region in 2023
Figure 31. APAC Antiandrogen Market Size Market Share by Type in 2023
Figure 32. APAC Antiandrogen Market Size Market Share by Application in 2023
Figure 33. China Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 37. India Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe Antiandrogen Market Size Market Share by Country in 2023
Figure 40. Europe Antiandrogen Market Size Market Share by Type (2019-2024)
Figure 41. Europe Antiandrogen Market Size Market Share by Application (2019-2024)
Figure 42. Germany Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 43. France Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa Antiandrogen Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa Antiandrogen Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa Antiandrogen Market Size Market Share by Application (2019-2024)
Figure 50. Egypt Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country Antiandrogen Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 56. APAC Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 57. Europe Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 59. United States Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 60. Canada Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 61. Mexico Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 62. Brazil Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 63. China Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 64. Japan Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 65. Korea Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 67. India Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 68. Australia Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 69. Germany Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 70. France Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 71. UK Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 72. Italy Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 73. Russia Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 74. Spain Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 75. Egypt Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 76. South Africa Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 77. Israel Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 78. Turkey Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries Antiandrogen Market Size 2025-2030 ($ Millions)
Figure 80. Global Antiandrogen Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global Antiandrogen Market Size Market Share Forecast by Application (2025-2030)